Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
11.70
+0.09 (0.78%)
Jun 6, 2025, 4:00 PM - Market closed
Bausch + Lomb Employees
Bausch + Lomb had 13,500 employees as of December 31, 2024. The number of employees increased by 200 or 1.50% compared to the previous year.
Employees
13,500
Change (1Y)
200
Growth (1Y)
1.50%
Revenue / Employee
$363,083
Profits / Employee
-$27,218
Market Cap
4.13B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13,500 | 200 | 1.50% |
Dec 31, 2023 | 13,300 | 400 | 3.10% |
Dec 31, 2022 | 12,900 | 400 | 3.20% |
Dec 31, 2021 | 12,500 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
BLCO News
- 22 hours ago - BLCO Investors Have Opportunity to Join Bausch + Lomb Corporation Fraud Investigation with the Schall Law Firm - Business Wire
- 16 days ago - Bausch + Lomb to Participate in the 2025 Jefferies Global Healthcare Conference - Business Wire
- 16 days ago - Bausch + Lomb Announces 2025 Annual Meeting of Shareholders Results - Business Wire
- 5 weeks ago - Bausch + Lomb Corporation (BLCO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Bausch + Lomb Announces First-Quarter 2025 Results - Business Wire
- 6 weeks ago - Bausch + Lomb Returning enVista® Intraocular Lenses to Market Following Voluntary Recall - Business Wire
- 2 months ago - Bausch + Lomb (BLCO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 2 months ago - Bronstein, Gewirtz & Grossman, LLC Encourages Bausch + Lomb (BLCO) Shareholders to Inquire about Securities Investigation - Accesswire